from Edison Investment Research Limited (LON:KEFI)
Edison issues report on Worldwide Healthcare Trust (WWH)
Edison Investment Research Limited
London, UK, 3 December 2025
Edison issues report on Worldwide Healthcare Trust (WWH) Edison issues report on Worldwide Healthcare Trust (LSE: WWH) Worldwide Healthcare Trust (WWH) delivered a strong H126 (to 30 September 2025), with NAV and share price total returns of +5.0% and +10.9%, respectively, significantly outperforming the benchmark’s -5.3% total return. This marks the trust’s best six-month period in the past decade. Co-managers Sven Borho and Trevor Polischuk, based at global healthcare specialist OrbiMed, attribute the performance to their continued focus on innovation and long-term growth, particularly in emerging (small-cap) biotech and Chinese stocks. Since its launch in April 1995 to the end of September 2025, WWH has generated average annual NAV total returns of +13.4%, beating the benchmark’s +10.9%. The recent drug pricing deal between President Trump and Pfizer has removed a long-term policy overhang that had weighed on the sector, and the managers believe that the healthcare sector is well-positioned for a catch-up, after a protracted period of underperformance. Click here to read the full report. All reports published by Edison are available to download free of charge from its website Edison is authorised and regulated by the Financial Conduct Authority. Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities. For more information, please contact Edison: +44 (0)20 3077 5700 Connect with Edison on:
LinkedIn www.linkedin.com/company/edison-group-/ YouTube www.youtube.com/edisonitv Dissemination of a CORPORATE NEWS, transmitted by EQS Group. |
2239380 03-Dec-2025